MedPath

ST250 as a Therapeutic Option for Head & Neck Reconstruction

Phase 1
Recruiting
Conditions
Tonsillitis
Interventions
Other: Comparator
Device: SupraTHEL 250
Registration Number
NCT06543823
Lead Sponsor
Alaa Emara
Brief Summary

To assess the use of SupraThel 250 for mucosal reconstruction in the Head \& Neck region. The membrane will be applied after tonsillectomy procedures and compared to bare wounds' healing

Detailed Description

After tonsillectomy procedures, the wound is usually left bare to heal. This causes severe pain postoperatively and postoperative hemorrhage. SupraTHEL 250 is a synthetic biodegradable PLA membrane which is proven as a skin membrane in burn wounds with excellent result. We therefore hypothesize that the use opf SupraTHEL 250 after tonsillectomy procedures will allow for faster , less painful healing of the wound bed which allows for a better quality of life for the patients.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
60
Inclusion Criteria
  • recurrent episodes of tonsillar infection
Exclusion Criteria
  • children
  • pregnant/ breastfeeding women
  • patients undergoing chemo / radiotherapy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Study groupComparatorThe wound bed is left bare after the tonsillectomy procedure
SupraTHEL 250 groupSupraTHEL 250The SupraTHEL 250 membrane is suture ionto the wound bed after the tonsillectomy procedure
Primary Outcome Measures
NameTimeMethod
Pain scoresupto 5 days postoperatively

Visual Analogue Scores (0-10; 0 lowest , 10 highest)

Secondary Outcome Measures
NameTimeMethod
Quality of Life , Tonsillectomy Outcome Inventory - 145 days Postoperative

assessment of patients quality of life according to a set of questions

Trial Locations

Locations (1)

MarienHospital

🇩🇪

Stuttgart, Baden-Wurttemberg, Germany

© Copyright 2025. All Rights Reserved by MedPath